PHAR Financials
Pharming Group Nv - Financial statements & key metrics
Stock Price
$17.35
Market Cap
$1.26B
P/E Ratio
445.0
EPS
$0.04
Income Statement Highlights
Most Recent Quarter: 2025-12-31
Revenue
$377.18M
Gross Profit
$331.56M
Operating Income
$19.37M
Net Income
$2.86M
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$499.81M
Total Liabilities
$222.79M
Shareholders Equity
$277.02M
Cash & Equivalents
$146.02M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$50.07M
CapEx
$751090
Free Cash Flow
$49.31M
Profitability Metrics
Gross Margin
87.9%
Operating Margin
0.0%
Net Margin
0.0%
ROE
0.0%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is PHAR revenue?
PHAR's most recent quarterly revenue was $377.18M. Annual revenue can be calculated by summing the four most recent quarters.
Is PHAR profitable?
PHAR reported a profit of $2.86M in the most recent quarter. The net profit margin is 0.0%.
What is PHAR market cap?
PHAR has a market capitalization of $1.26B, making it a small-cap stock.
Does PHAR have debt?
View PHAR's balance sheet for debt information.
What is PHAR cash flow?
PHAR's most recent quarterly free cash flow was $49.31M.